HIV molecular immunology database
Found 1 matching record:
HXB2 Location | Gag(162-172) | Gag Epitope Map
View variants at this location |
|||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Epitope |
KAFSPEVIPMF
|
Epitope Alignment | |||||||||||||
Variants |
|
||||||||||||||
Epitope Name | KF11 | ||||||||||||||
Species (MHC/HLA) | human(B*57:01) |
Showing all: 4 variant(s).
Variant ID. | 3344 |
---|---|
Epitope Seq. | KAFSPEVIPMF |
Variant Seq. | KAFSPEVIPMs |
Mutations | F/S |
Epitope Location | F11S |
HXB2 Location | F172S |
Mutation Type | OV: observed variant |
Epitope Subtype | B |
Variant Subtype | B |
Method | HLA binding, Intracellular cytokine staining, Sequence |
Note | Variant KAFSPEVIPMs was seen in 1/3 HRP subjects (patient P1). |
Variant ID. | 3345 |
---|---|
Epitope Seq. | KAFSPEVIPMF |
Variant Seq. | KAFSPEVIPMt |
Mutations | F/T |
Epitope Location | F11T |
HXB2 Location | F172T |
Mutation Type | OV: observed variant |
Epitope Subtype | B |
Variant Subtype | B |
Method | HLA binding, Intracellular cytokine staining, Sequence |
Note | Variant KAFSPEVIPMt was seen in 1/3 HRP (patient P1) and 1/3 LRP (patient P6) subjects. |
Variant ID. | 3346 |
---|---|
Epitope Seq. | KAFSPEVIPMF |
Variant Seq. | KAFSPEiIPMF |
Mutations | V/I |
Epitope Location | V7I |
HXB2 Location | V168I |
Mutation Type | OV: observed variant |
Epitope Subtype | B |
Variant Subtype | B |
Method | HLA binding, Intracellular cytokine staining, Sequence |
Note | Variant KAFSPEiIPMF was seen in 1/3 HRP (patient P1) and 1/3 LRP (patient P6) subjects. |
Variant ID. | 3347 |
---|---|
Epitope Seq. | KAFSPEVIPMF |
Variant Seq. | KAsSPEVIPMF |
Mutations | F/S |
Epitope Location | F3S |
HXB2 Location | F164S |
Mutation Type | OV: observed variant |
Epitope Subtype | B |
Variant Subtype | B |
Method | HLA binding, Intracellular cytokine staining, Sequence |
Note | Variant KAsSPEVIPMF was seen in 1/3 LRP (patient P6) subjects. |
Buggert2014 Marcus Buggert, Melissa M. Norström, Marco Salemi, Frederick M. Hecht, and Annika C. Karlsson. Functional Avidity and IL-2/Perforin Production Is Linked to the Emergence of Mutations within HLA-B*5701-Restricted Epitopes and HIV-1 Disease Progression. J. Immunol., 192(10):4685-4696, 15 May 2014. PubMed ID: 24740510. Show all entries for this paper.